Novozymes A/S
NVZMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $180 | $100 | $97 | $150 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $2 | $8 | $1 | $0 |
| Enterprise Value | $182 | $107 | $97 | $149 |
| Revenue | $29 | $18 | $18 | $15 |
| % Growth | 59.7% | 2% | 17.4% | – |
| Gross Profit | $15 | $10 | $10 | $9 |
| % Margin | 52% | 54.3% | 54.6% | 57.8% |
| EBITDA | $8 | $6 | $6 | $5 |
| % Margin | 28.2% | 31.5% | 32.6% | 33.9% |
| Net Income | $2 | $3 | $4 | $3 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 0.67 | 10.88 | 13.19 | 11.23 |
| % Growth | -93.8% | -17.5% | 17.5% | – |
| Operating Cash Flow | $1 | $4 | $4 | $4 |
| Capital Expenditures | -$0 | -$2 | -$3 | -$1 |
| Free Cash Flow | $1 | $2 | $1 | $3 |